#COVID19 $BNTX (+33% PM) BioNTech and Pfizer received German regulatory approval to begin Ph 1/2 clinical trial of BNT162 vaccine to prevent COVID-19 infection. $PFE

FIH trial expected to begin in Apr ‘20.

U.S. regulatory approval is expected shortly.

https://t.co/P1yNG8anJ0